Afuco™ Anti-Human FcRn ADCC Therapeutic Antibody (HL161), ADCC Enhanced
Anti-FcRn ADCC Enhanced Antibody (HL161) is an ADCC enhanced antibody produced by our Afuco™ platform. HL161 is a novel anti-FcRn antibody that can be used as a new therapeutic option for pathogenic IgG-mediated autoimmune diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-262CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FcRn |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |